• Quick Order
  • Careers
  • Support
hTERT Melanocyte CRL-4064 TRP1 Dapi.jpg

SOT 63rd Annual Meeting and ToxExpo 2024

Salt Palace Convention Center, Salt Lake City, Utah

March 10, 2024 - March 14, 2024

The SOT 63rd Annual Meeting and ToxExpo brought together a community of scientists across numerous disciplines to discuss the latest advancements in toxicologic sciences and toxicity testing. Check out our poster presentation from the event and explore our resources below to see how we can support your toxicology research.

Did you miss us at booth #401 and would like to speak to one of ATCC’s representatives about a product or service? Make an appointment with us so we can discuss your needs.

Contact us

Join our poster sessions

Novel Immortalized Pulmonary Artery Endothelial Cell Line Recapitulates the Characteristics of Primary Cells
Presenter: Xiangshan Zhao, PhD, Senior Scientist, ATCC
Date: Wednesday, March 13, 2024
Time: 9:15 AM – 11:15 AM
Abstract number: 4670
Poster board number: P557

Get a copy of the poster

Meet the presenter

Headshot of Xiangshan Zhao

Xiangshan Zhao, PhD

Senior Scientist, Cell Biology R&D, ATCC

Xiangshan Zhao, PhD, is a Senior Scientist at ATCC. He has extensive experience in cell line development and cell-based assay development. Dr. Zhao leads the Immortalized Primary Cells program developing innovative immortalized cell lines for research, drug screening, cell therapy, and toxicology studies.

Kidney glomeruli

Toxicology testing products

ATCC knows that worthwhile science takes time, especially in the toxicology, pre-clinical stages of drug development. It is critical that the standards and model organisms used in toxicological testing are reliable and authenticated. We can help streamline your research by providing the most authenticated, advanced, and functional models available. Let ATCC revolutionize and accelerate your toxicology studies in every phase of the research and testing process.

ATCC provides the cells, media, and reagents needed to explore each step of the in vitro preclinical testing process—from modeling, screening, and characterization to exploratory toxicology to pharmacokinetics and metabolism. We provide renal, neural, airway, and skin models for such applications as high-content screening, 3D culture, spheroid culture, permeability assays, metabolic stability and survival studies, transport activity measurement, and more.

Explore toxicology tools

Learn more about our toxicology portfolio

Red and blue hek 293 stained protein. Webinar

ATCC’s Toxicology Portfolio: Tools for Every Stage of Your Preclinical Drug Development Workstream Webinar

This webinar discusses how modified primary cells are effective tools that provide tissue-relevant results and reproducibility for any cell-based assay, including toxicology assays.

Kidney glomeruli rotate. Webinar

Enable Renal ADME and Pharmaco-kinetics Studies Using Solute Carrier Transporter Cells

hTERT-immortalized primary cells are genetically modified such that the cells exhibit the growth characteristics of a continuous cell but maintain the physiology of a primary cell. This webinar focuses on hTERT-immortalized primary renal epithelial cells and provides application data to illustrate how these kidney models can easily be incorporated into your toxicity testing workflow.

Ker-ct filiggrin epithelial cells. Webinar

3-D Models for Absorption and Cosmetic Toxicity Studies: Primary and Immortalized Epidermal Cells

This webinar discusses how immortalized primary epidermal cells recapitulate key barrier, growth, differentiation, and other physiologically relevant features, making them useful tools for toxicological applications such as high-throughput screening.


Contact us today

Your ATCC sales representative stands ready to discuss your research needs and provide you with personalized care. Please complete our form to let us know how we can help, and we will start working on your needs right away.

We will not share your information outside of our distributors network and solely use it to send relevant communications.
Your form was successfully submitted